Paclitaxel-Avelumab for Angiosarcoma

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2018
To investigate the efficacy of Avelumab when given in combination with paclitaxel as a first line treatment for the patients with inoperable angiosarcoma.
Epistemonikos ID: c254297baa076dbb83ad7e2694306aef6db06593
First added on: May 21, 2024